SOLENO THERAPEUTICS INC (SLNO)
US8342033094 - Common Stock
| MRQ (2024-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 42.85M | 169.68M | 14.60M | 21.30M | 49.22M | |||
| Marketable Securities | 106.78M | N/A | N/A | N/A | N/A | |||
| Receivables | N/A | N/A | N/A | N/A | N/A | |||
| Inventories | N/A | N/A | N/A | N/A | N/A | |||
| Other Current Assets | 1.60M | 1.68M | 1.05M | 1.12M | 1.02M | |||
| Total Current Assets | 151.22M | 171.36M | 15.65M | 22.42M | 50.24M | |||
| Non-Current Assets | ||||||||
| PPE Net | 365.00K | 419.00K | 160.00K | 450.00K | 160.00K | |||
| Investments And Advances | 8.82M | N/A | N/A | N/A | N/A | |||
| Goodwill | N/A | N/A | N/A | N/A | N/A | |||
| Intangibles | 8.26M | 8.75M | 10.69M | 12.64M | 14.58M | |||
| Other Non-Current Assets | 165.00K | 165.00K | 0.00 | 40.00K | 0.00 | |||
| Total Non-Current Assets | 17.61M | 9.33M | 10.85M | 13.13M | 14.74M | |||
| TOTAL ASSETS | 168.84M | 180.69M | 26.50M | 35.55M | 64.98M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | 0.00 | 10.00K | |||
| Accrued Expenses | 3.93M | 6.80M | 5.05M | 4.43M | 4.93M | |||
| Accounts Payable | 8.02M | 3.15M | 1.78M | 3.25M | 3.49M | |||
| Other Current Liabilities | 1.51M | 1.55M | 480.00K | 320.00K | 190.00K | |||
| Total Current Liabilities | 13.46M | 11.51M | 7.31M | 8.01M | 8.62M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 11.99M | 11.68M | 8.84M | 9.75M | 10.82M | |||
| Total Non-Current Liabilities | 11.99M | 11.68M | 8.84M | 9.75M | 10.82M | |||
| TOTAL LIABILITIES | 25.45M | 23.18M | 16.15M | 17.76M | 19.44M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -297.81M | -276.41M | -237.42M | -213.36M | -182.45M | |||
| Additional Paid In Capital | 441.27M | 433.88M | 247.76M | 231.07M | 227.91M | |||
| Common Shares | 33.00K | 32.00K | 10.00K | 80.00K | 80.00K | |||
| Other Shareholders' Equity | -106.00K | N/A | N/A | N/A | N/A | |||
| Shares Outstanding | 33.34M | 31.68M | 8.16M | 5.32M | 5.31M | |||
| Tangible Book Value per Share | 4.05 | 4.70 | -0.04 | 0.97 | 5.83 | |||
| Total Shareholders' Equity | 143.39M | 157.51M | 10.35M | 17.79M | 45.55M | |||
| TOTAL LIABILITIES AND EQUITY | 168.84M | 180.69M | 26.50M | 35.55M | 64.98M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | N/A | N/A | |||
| Current Ratio | 11.23 | 14.89 | 2.14 | 2.80 | 5.83 | |||
| Return On Assets (ROA) | -30.82% | -21.58% | -90.83% | -86.95% | -37.92% | |||
| Return On Equity (ROE) | -36.29% | -24.75% | -232.56% | -173.75% | -54.09% | |||
All data in USD